ALL KEYWORDSMeningiomaRelated SpecialistsShowing 3 of 20Jennifer MoliternoMDSylvia KurzMD, PhDMichael DiLunaMDMore Related SpecialistsRelated Fact SheetsMeningiomasRelated Clinical TrialsPhase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway MutationsBrain & Other Nervous System CancersRelated NewsPatient Stories, Family HealthRelated DepartmentsShowing 3 of 25Brain Tumor SurgeryNeurotraumaNeurosurgeryMore Related Departments
